HYDROXYFLAVONE DERIVATIVES AS TAU PROTEIN KINASE 1 INHIBITORS
申请人:MITSUBISHI CHEMICAL CORPORATION
公开号:EP1115718A1
公开(公告)日:2001-07-18
[EN] HYDROXYFLAVONE DERIVATIVES AS TAU PROTEIN KINASE 1 INHIBITORS<br/>[FR] DERIVES D'HYDROXYFLAVONE UTILISES COMME INHIBITEURS DE TAU-PROTEINE-KINASE 1
申请人:MITSUBISHI CHEM CORP
公开号:WO2000017184A1
公开(公告)日:2000-03-30
A medicament for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity or a neurodegenerative disease which comprises as an active ingredient a substance selected from the group consisting of a hydroxyflavone derivative represented by formula (I) and a salt thereof, and a solvate thereof and a hydrate thereof, wherein R1 represents hydrogen atom or hydroxyl group; R2 represents hydrogen atom or a C¿1?-C18 alkyl group which may have one or more C6-C14 aryl groups; and Ar represents a C6-C14 aryl group which may be substituted or an aromatic heterocyclic group which may be substituted.
Patonay, Tamas; Levai, Albert; Hegedus Laszlo, Bulletin de la Societe Chimique de France, 1997, vol. 134, # 7, p. 653 - 668